Compare KKR & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KKR | ELV |
|---|---|---|
| Founded | 1976 | 1944 |
| Country | United States | United States |
| Employees | 4200 | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.8B | 88.0B |
| IPO Year | 2007 | 2001 |
| Metric | KKR | ELV |
|---|---|---|
| Price | $93.29 | $394.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 19 |
| Target Price | $132.85 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 3.3M | 1.1M |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | 0.75% | ★ 1.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 14.73 |
| Revenue | $19,464,307,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $25.41 | $3.07 |
| P/E Ratio | $44.27 | ★ $26.86 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $82.67 | $274.89 |
| 52 Week High | $144.84 | $436.24 |
| Indicator | KKR | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 33.50 | 41.31 |
| Support Level | $85.85 | $386.93 |
| Resistance Level | $99.92 | $407.67 |
| Average True Range (ATR) | 2.93 | 9.86 |
| MACD | -0.82 | -2.76 |
| Stochastic Oscillator | 4.34 | 4.05 |
KKR is one of the world's largest alternative-asset managers, with $796.5 billion in total managed assets, including $638.4 billion in fee-earning assets under management, at the end of June 2026. The company has two core segments: asset management (which includes private markets—private equity, credit, infrastructure, energy, and real estate—and public markets—primarily credit and hedge/investment fund platforms) and insurance (following the firm's initial investment in, and then ultimate purchase of, Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance).
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.